Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review

Background: Glycogen-rich clear cell breast carcinoma is a rare histological breast cancer subtype. Its prognosis may vary depending on specific clinical and pathological characteristics such as low grade, strong positivity of estrogen receptor (ER) expression and early diagnosis. Case Presentation:...

Full description

Bibliographic Details
Main Authors: Vilma Ratti, Olivia Pagani
Format: Article
Language:English
Published: Karger Publishers 2015-11-01
Series:Case Reports in Oncology
Subjects:
Online Access:http://www.karger.com/Article/FullText/441838
id doaj-59404d1124cb4dc79f9287d3c6793f30
record_format Article
spelling doaj-59404d1124cb4dc79f9287d3c6793f302020-11-24T22:35:03ZengKarger PublishersCase Reports in Oncology1662-65752015-11-018347247710.1159/000441838441838Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature ReviewVilma RattiOlivia PaganiBackground: Glycogen-rich clear cell breast carcinoma is a rare histological breast cancer subtype. Its prognosis may vary depending on specific clinical and pathological characteristics such as low grade, strong positivity of estrogen receptor (ER) expression and early diagnosis. Case Presentation: We present the case of a 53-year-old woman with a bleeding 10-cm-diameter mass in the left breast. The histological examination showed a poorly differentiated tumor with malignant cells characterized by abundant clear cytoplasm. The diagnosis of clear cell carcinoma was based on the histological characteristics of the tumor, and a nonmammary origin was initially ruled out. The tumor was triple negative [i.e. ER, progesterone receptor (PR) and HER2 negative]. Four months after the initial locoregional treatment, the patient developed lung and distant lymph node metastases. Conclusions: Glycogen-rich clear cell carcinoma of the breast is a rare tumor. Early diagnosis, absence of lymph node metastases and ER/PR positivity are associated with a better prognosis, as in other common breast cancer subtypes.http://www.karger.com/Article/FullText/441838Breast cancerGlycogen-rich clear cell carcinoma
collection DOAJ
language English
format Article
sources DOAJ
author Vilma Ratti
Olivia Pagani
spellingShingle Vilma Ratti
Olivia Pagani
Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review
Case Reports in Oncology
Breast cancer
Glycogen-rich clear cell carcinoma
author_facet Vilma Ratti
Olivia Pagani
author_sort Vilma Ratti
title Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review
title_short Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review
title_full Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review
title_fullStr Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review
title_full_unstemmed Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review
title_sort clear cell carcinoma of the breast: a rare breast cancer subtype - case report and literature review
publisher Karger Publishers
series Case Reports in Oncology
issn 1662-6575
publishDate 2015-11-01
description Background: Glycogen-rich clear cell breast carcinoma is a rare histological breast cancer subtype. Its prognosis may vary depending on specific clinical and pathological characteristics such as low grade, strong positivity of estrogen receptor (ER) expression and early diagnosis. Case Presentation: We present the case of a 53-year-old woman with a bleeding 10-cm-diameter mass in the left breast. The histological examination showed a poorly differentiated tumor with malignant cells characterized by abundant clear cytoplasm. The diagnosis of clear cell carcinoma was based on the histological characteristics of the tumor, and a nonmammary origin was initially ruled out. The tumor was triple negative [i.e. ER, progesterone receptor (PR) and HER2 negative]. Four months after the initial locoregional treatment, the patient developed lung and distant lymph node metastases. Conclusions: Glycogen-rich clear cell carcinoma of the breast is a rare tumor. Early diagnosis, absence of lymph node metastases and ER/PR positivity are associated with a better prognosis, as in other common breast cancer subtypes.
topic Breast cancer
Glycogen-rich clear cell carcinoma
url http://www.karger.com/Article/FullText/441838
work_keys_str_mv AT vilmaratti clearcellcarcinomaofthebreastararebreastcancersubtypecasereportandliteraturereview
AT oliviapagani clearcellcarcinomaofthebreastararebreastcancersubtypecasereportandliteraturereview
_version_ 1725724983735353344